CID 132246793

Tgf-|ari inhibitor 1

Structural Information

Molecular Formula
C21H19N7O
SMILES
CC1=NC(=CC=C1)C2=NN3CCCC3=C2C4=C(N5C(=NC=N5)C=C4)/C=C/C(=O)N
InChI
InChI=1S/C21H19N7O/c1-13-4-2-5-15(25-13)21-20(17-6-3-11-27(17)26-21)14-7-10-19-23-12-24-28(19)16(14)8-9-18(22)29/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,22,29)/b9-8+
InChIKey
FSQGWBXWGNWEAV-CMDGGOBGSA-N
Compound name
(E)-3-[6-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-[1,2,4]triazolo[1,5-a]pyridin-5-yl]prop-2-enamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

12
Patents

385.1651 Da
Monoisotopic Mass

1.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 386.17238 191.6
[M+Na]+ 408.15432 202.0
[M-H]- 384.15782 197.8
[M+NH4]+ 403.19892 201.9
[M+K]+ 424.12826 194.7
[M+H-H2O]+ 368.16236 180.8
[M+HCOO]- 430.16330 208.8
[M+CH3COO]- 444.17895 200.9
[M+Na-2H]- 406.13977 189.3
[M]+ 385.16455 193.7
[M]- 385.16565 193.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe